HomeCompareTPHIF vs PFE

TPHIF vs PFE: Dividend Comparison 2026

TPHIF yields 110.50% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TPHIF wins by $5.88M in total portfolio value
10 years
TPHIF
TPHIF
● Live price
110.50%
Share price
$1.81
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.93M
Annual income
$2,132,830.87
Full TPHIF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — TPHIF vs PFE

📍 TPHIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTPHIFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TPHIF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TPHIF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TPHIF
Annual income on $10K today (after 15% tax)
$9,392.27/yr
After 10yr DRIP, annual income (after tax)
$1,812,906.24/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, TPHIF beats the other by $1,790,586.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TPHIF + PFE for your $10,000?

TPHIF: 50%PFE: 50%
100% PFE50/50100% TPHIF
Portfolio after 10yr
$2.99M
Annual income
$1,079,544.80/yr
Blended yield
36.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

TPHIF
No analyst data
Altman Z
0.5
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TPHIF buys
0
PFE buys
0
No recent congressional trades found for TPHIF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTPHIFPFE
Forward yield110.50%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$5.93M$49.6K
Annual income after 10y$2,132,830.87$26,258.71
Total dividends collected$5.35M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TPHIF vs PFE ($10,000, DRIP)

YearTPHIF PortfolioTPHIF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$21,750$11,049.72$9,153$693.39+$12.6KTPHIF
2$45,733$22,460.60$8,593$849.25+$37.1KTPHIF
3$93,072$44,137.91$8,336$1,066.78+$84.7KTPHIF
4$183,537$83,949.70$8,437$1,384.80+$175.1KTPHIF
5$351,102$154,717.47$9,013$1,875.40+$342.1KTPHIF
6$652,287$276,608.54$10,306$2,680.72+$642.0KTPHIF
7$1,178,220$480,272.57$12,820$4,101.38+$1.17MTPHIF
8$2,071,454$810,758.34$17,673$6,826.70+$2.05MTPHIF
9$3,548,616$1,332,160.25$27,543$12,591.86+$3.52MTPHIF
10$5,929,850$2,132,830.87$49,560$26,258.71+$5.88MTPHIF

TPHIF vs PFE: Complete Analysis 2026

TPHIFStock

Top Frontier Investment Holdings, Inc., together with its subsidiaries, engages in the food and beverage, packaging, energy, mining, fuel and oil, infrastructure, cement, and real estate property management and development businesses worldwide. It offers poultry, fresh meat, and refrigerated and canned meat products; butter, margarine, cheese, milk, ice cream, jelly-based snacks and desserts, specialty oils, salad aids, and snacks and condiments; flour mixes; flour and bakery ingredients; and coffee and related products. The company also offers feeds; poultry and livestock farming; grain terminal handling; and food services, as well as fermented, malt-based, and non-alcoholic beverages; liquor, Chinese wine, brandy, rum, vodka, and other liquor products; and value-added refrigerated meats, such as hotdogs, nuggets, bacon, hams, ready-to-heat meal, seafood lines, and meat free products, as well as operates franchises. In addition, it offers glass containers and molds, polyethylene terephthalate (PET) bottles and preforms, PET recycling, plastic closures, corrugated cartons, woven polypropylene, kraft sacks and paperboards, pallets, flexible packaging, plastic crates, plastic floorings, plastic films, plastic trays, plastic pails and tubs, metal closures and two-piece aluminum cans, woven products, and industrial laminates and radiant barriers; and crate and plastic pallet leasing, PET bottle filling graphics design, packaging research and testing, packaging development and consultation, and contract packaging and trading services. Further, it sells, retails, and distributes power; refines and markets petroleum products; develops and constructs toll roads, airports, railways, and bulk water. Additionally, it explores, develops, and utilizes nickel, cobalt, chrome, iron, gold, and other mineral deposits; produces and sells cement; and develops, sells, and leases real properties. The company was incorporated in 2008 and is headquartered in Makati City, the Philippines.

Full TPHIF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this TPHIF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TPHIF vs SCHDTPHIF vs JEPITPHIF vs OTPHIF vs KOTPHIF vs MAINTPHIF vs JNJTPHIF vs MRKTPHIF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.